$APYP
APPYEA, INC Stock $apyp

$apyp Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-K Financial Statement

#000164033419002076 Filed on October 18, 2019

Income Statement

Concept	2019 Q2	2019	2018 Q2
Revenue	$0.00	$345.00	-$10.00K
YoY Change	-100.0%	-91.88%
Cost Of Revenue		$345.00
YoY Change		-74.43%
Gross Profit		$0.00
YoY Change		-100.0%
Gross Profit Margin		0.0%
Selling, General & Admin	$40.00K	$160.0K	$110.0K
YoY Change	-63.64%	-73.33%	-50.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$7.300K	$0.00
YoY Change		-77.0%	-100.0%
% of Gross Profit
Operating Expenses	$30.00K	$164.3K	$140.0K
YoY Change	-78.57%	-74.19%	-39.13%
Operating Profit		-$163.9K
YoY Change		-74.07%
Interest Expense	$1.870M	-$239.0K	-$500.0K
YoY Change	-474.0%	-43.72%	257.14%
% of Operating Profit
Other Income/Expense, Net		-$900.9K
YoY Change		-33.86%
Pretax Income	$1.630M	-$1.060M	-$650.0K
YoY Change	-350.77%	-46.73%	75.68%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	$1.630M	-$1.065M	-$650.0K
YoY Change	-350.77%	-46.61%	75.68%
Net Earnings / Revenue		-308640.58%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.07	-$0.09	-$0.10
COMMON SHARES
Basic Shares Outstanding	4.001B shares		1.200B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.00K	$50.00K	$50.00K
YoY Change	0.0%	0.0%	25.0%
Cash & Equivalents	$45.06K	$50.00K	$47.20K
Short-Term Investments
Other Short-Term Assets	$10.00K	$10.00K
YoY Change
Inventory
Prepaid Expenses	$9.500K
Receivables
Other Receivables
Total Short-Term Assets	$54.56K	$50.00K	$47.20K
YoY Change	15.59%	0.0%	10.87%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00	$7.300K
YoY Change		-100.0%	-81.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$7.300K
YoY Change	-100.0%		-81.3%
TOTAL ASSETS
Total Short-Term Assets	$54.56K	$50.00K	$47.20K
Total Long-Term Assets	$0.00	$0.00	$7.300K
Total Assets	$54.56K	$50.00K	$54.50K
YoY Change	0.11%	0.0%	-33.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$40.00K	$40.00K	$280.0K
YoY Change	-85.71%	-85.71%	4572.12%
Accrued Expenses	$2.496K	$0.00	$2.484K
YoY Change	0.48%	-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$320.0K	$320.0K	$300.0K
YoY Change	6.67%	6.67%	76.47%
Total Short-Term Liabilities	$1.030M	$1.030M	$1.904M
YoY Change	-45.9%	-45.79%	283.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.030M	$1.030M	$1.904M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.030M	$1.030M	$1.904M
YoY Change	-45.9%	-45.79%	283.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.842M		-$6.777M
YoY Change	15.71%		41.7%
Common Stock	$509.6K		$124.0K
YoY Change	310.81%		138.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$975.6K	-$980.0K	-$1.850M
YoY Change
Total Liabilities & Shareholders Equity	$54.56K	$50.00K	$54.50K
YoY Change	0.11%	0.0%	-33.22%

Cashflow Statement

Concept	2019 Q2	2019	2018 Q2
OPERATING ACTIVITIES
Net Income	$1.630M	-$1.065M	-$650.0K
YoY Change	-350.77%	-46.61%	75.68%
Depreciation, Depletion And Amortization	$0.00	$7.300K	$0.00
YoY Change		-77.0%	-100.0%
Cash From Operating Activities	-$40.00K	-$102.3K	-$10.00K
YoY Change	300.0%	-24.55%	-87.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$0.00		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	$100.1K	60.00K
YoY Change	-83.33%	-39.38%	-40.0%
NET CHANGE
Cash From Operating Activities	-40.00K	-$102.3K	-10.00K
Cash From Investing Activities	0.000		0.000
Cash From Financing Activities	10.00K	$100.1K	60.00K
Net Change In Cash	-30.00K	-$2.140K	50.00K
YoY Change	-160.0%	-146.23%	150.0%
FREE CASH FLOW
Cash From Operating Activities	-$40.00K	-$102.3K	-$10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	dei	Entity Registrant Name EntityRegistrantName	APPYEA, INC
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001568969
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54556	usd
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54496	usd
CY2018Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	47196	usd
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5161140774	shares
CY2018Q4	dei	Entity Public Float EntityPublicFloat	269000	usd
CY2019Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	45056	usd
CY2019Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9500	usd
CY2019Q2	us-gaap	Assets Current AssetsCurrent	54556	usd
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7300	usd
CY2019Q2	us-gaap	Assets Assets	54556	usd
CY2018Q2	us-gaap	Assets Assets	54496	usd
CY2019Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	44393	usd
CY2018Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	275312	usd
CY2019Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3506	usd
CY2018Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	224000	usd
CY2019Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	315232	usd
CY2018Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	290823	usd
CY2019Q2	us-gaap	Convertible Debt ConvertibleDebt		usd
CY2018Q2	us-gaap	Convertible Debt ConvertibleDebt	8977	usd
CY2019Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	88224	usd
CY2018Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	88087	usd
CY2019Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	578812	usd
CY2018Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1016865	usd
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1030167	usd
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1904064	usd
CY2019Q2	us-gaap	Liabilities Liabilities	1030167	usd
CY2018Q2	us-gaap	Liabilities Liabilities	1904064	usd
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue	975	usd
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	509593	usd
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	124047	usd
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6308023	usd
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4740277	usd
CY2019Q2	apyp	Stock Payable StockPayable	47727	usd
CY2018Q2	apyp	Stock Payable StockPayable	62727	usd
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7841929	usd
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6777119	usd
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-975611	usd
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-1849568	usd
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	250570	usd
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	257870	usd
CY2018Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	81968	usd
CY2019Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	15000	usd
CY2018Q2	us-gaap	Assets Current AssetsCurrent	47196	usd
CY2018Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	60000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	60000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	9750000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	9750000	shares
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000000	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1240477060	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5095935524	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1240477060	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5095935524	shares
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	345	usd
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1349	usd
CY2019	us-gaap	Revenue From Related Parties RevenueFromRelatedParties		usd
CY2018	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2900	usd
CY2019	us-gaap	Revenues Revenues	345	usd
CY2018	us-gaap	Revenues Revenues	4249	usd
CY2019	us-gaap	Professional Fees ProfessionalFees	46103	usd
CY2018	us-gaap	Professional Fees ProfessionalFees	418044	usd
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110855	usd
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	186574	usd
CY2019	us-gaap	Depreciation Depreciation	7300	usd
CY2018	us-gaap	Depreciation Depreciation	31744	usd
CY2019	us-gaap	Operating Expenses OperatingExpenses	164258	usd
CY2018	us-gaap	Operating Expenses OperatingExpenses	636362	usd
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-163913	usd
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-632113	usd
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-464691	usd
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-912590	usd
CY2019	us-gaap	Interest Expense InterestExpense	-238956	usd
CY2018	us-gaap	Interest Expense InterestExpense	-424553	usd
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-197250	usd
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2019	us-gaap	Equity Method Investment Deferred Gain On Sale EquityMethodInvestmentDeferredGainOnSale		usd
CY2018	us-gaap	Equity Method Investment Deferred Gain On Sale EquityMethodInvestmentDeferredGainOnSale	-476	usd
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-24524	usd
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-900897	usd
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1362143	usd
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-1064810	usd
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-1994256	usd
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2411256185	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	988229338	shares
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	-415210	usd
CY2018	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	32000	usd
CY2018	apyp	Common Stock Issued For The Settlement Of Agreement Amount CommonStockIssuedForTheSettlementOfAgreementAmount	67500	usd
CY2018	apyp	Common Stock Issued Exchanged For Common Stock Payable Amount CommonStockIssuedExchangedForCommonStockPayableAmount	200	usd
CY2018	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	460198	usd
CY2018	us-gaap	Profit Loss ProfitLoss	-1994256	usd
CY2019	apyp	Preferred Stock Issued For Settlement Of Debt Related Party Amount PreferredStockIssuedForSettlementOfDebtRelatedPartyAmount	712500	usd
CY2019	apyp	Common Stock Issued In Conjunction With Convertible Note Amount CommonStockIssuedInConjunctionWithConvertibleNoteAmount	15000	usd
CY2019	apyp	Common Stock Issued Exchanged For Common Stock Payable Amount CommonStockIssuedExchangedForCommonStockPayableAmount		usd
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1211267	usd
CY2019	us-gaap	Profit Loss ProfitLoss	-1064810	usd
CY2019	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2018	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	32000	usd
CY2019	apyp	Common Stock Issued For Settlement Of Agreement CommonStockIssuedForSettlementOfAgreement		usd
CY2018	apyp	Common Stock Issued For Settlement Of Agreement CommonStockIssuedForSettlementOfAgreement	67500	usd
CY2019	us-gaap	Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1 NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1	197250	usd
CY2018	us-gaap	Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1 NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1		usd
CY2019	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal		usd
CY2018	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	24524	usd
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	171968	usd
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	329219	usd
CY2019	apyp	Loss On Investment In Equity Method Investee LossOnInvestmentInEquityMethodInvestee		usd
CY2018	apyp	Loss On Investment In Equity Method Investee LossOnInvestmentInEquityMethodInvestee	476	usd
CY2019	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal		usd
CY2018	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	15000	usd
CY2019	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	464691	usd
CY2018	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	912590	usd
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-9500	usd
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-669	usd
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	269319	usd
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	64506	usd
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	96000	usd
CY2019	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	66987	usd
CY2018	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	80334	usd
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-102277	usd
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-135550	usd
CY2019	us-gaap	Equity Method Investment Unrealized Intercompany Profit Loss Not Eliminated Amount EquityMethodInvestmentUnrealizedIntercompanyProfitLossNotEliminatedAmount		usd
CY2018	us-gaap	Equity Method Investment Unrealized Intercompany Profit Loss Not Eliminated Amount EquityMethodInvestmentUnrealizedIntercompanyProfitLossNotEliminatedAmount	-25000	usd
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25000	usd
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200	usd
CY2019	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	100000	usd
CY2018	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	142167	usd
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	8333	usd
CY2019	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	437	usd
CY2018	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	21098	usd
CY2019	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	-300	usd
CY2018	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	-6619	usd
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100137	usd
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	165179	usd
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2140	usd
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4629	usd
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47196	usd
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42567	usd
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45056	usd
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2019	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2018	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2019	apyp	Preferred Stock Issued For Settlement Of Debt Related Party PreferredStockIssuedForSettlementOfDebtRelatedParty	285000	usd
CY2018	apyp	Preferred Stock Issued For Settlement Of Debt Related Party PreferredStockIssuedForSettlementOfDebtRelatedParty		usd
CY2019	apyp	Common Stock Issued In Conjunction With Convertible Notes CommonStockIssuedInConjunctionWithConvertibleNotes	15000	usd
CY2018	apyp	Common Stock Issued In Conjunction With Convertible Notes CommonStockIssuedInConjunctionWithConvertibleNotes		usd
CY2019	us-gaap	Proceeds From Repayment Of Loans To Purchase Common Stock ProceedsFromRepaymentOfLoansToPurchaseCommonStock	15000	usd
CY2018	us-gaap	Proceeds From Repayment Of Loans To Purchase Common Stock ProceedsFromRepaymentOfLoansToPurchaseCommonStock		usd
CY2019	apyp	Issuance Of Common Stock For Conversion Of Debt And Accrued Interest IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest	223523	usd
CY2018	apyp	Issuance Of Common Stock For Conversion Of Debt And Accrued Interest IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest	164657	usd
CY2019	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	987744	usd
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	295541	usd
CY2019	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	100000	usd
CY2018	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	285500	usd
CY2019	us-gaap	Nature Of Operations NatureOfOperations	<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN"><p style="margin:0px;Font:10pt Times New Roman;padding:0px">AppYea, Inc. (“AppYea”, “the Company”, “we” or “us”) was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">The Company incorporated a wholly-owned subsidiary, “AppYea Holdings, Inc.” in state of South Dakota on January 13, 2017 and “The Diagnostic Centers Inc.” in State of South Dakota on August 2, 2017.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">Through its wholly owned subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics, hospitals, long term care facilities, healthcare groups, and other healthcare providers.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">During the quarter ended March 31, 2019 the Company entered into a management and advisory agreement with Hempori, Inc. to assist the Company in identifying and managing the Company’s overall business strategy and opportunities to enter the hemp based Cannabidiol (CBD) industry. Additionally, the Company entered into an exclusive CBD infused beverage licensing agreement with the Prouty Company to market flavored and non-flavored beverages in various formulas infused with CBD to achieve the following “mood enhancing” affects: Energy, Calm, Focus, and Sleep.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">The Company’s common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol “APYP”. The first day of trading on the OTC Markets was December 15, 2014.</p></div></div>
CY2019	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. We evaluate all of our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company used a Black Scholes valuation model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p></div>
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires that management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</p></div>
CY2019	apyp	Fair Value Assets Measured On Recurring Basis FairValueAssetsMeasuredOnRecurringBasis	<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN"><p style="margin:0px;Font:10pt Times New Roman;padding:0px"> </p><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"><tr><td style="BORDER-BOTTOM: 1px solid" valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>June 30, 2019</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 1</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 2</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 3</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Total</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Assets</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">None</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td></tr><tr bgcolor="#cceeff"><td></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Liabilities</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">Derivative liabilities</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">578,812</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">578,812</p></td><td valign="bottom" width="1%"></td></tr></table><p style="margin:0px;Font:10pt Times New Roman;padding:0px"> </p><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"><tr><td style="BORDER-BOTTOM: 1px solid" valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>June 30, 2018</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 1</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 2</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 3</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Total</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Assets</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">None</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td></tr><tr bgcolor="#cceeff"><td></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Liabilities</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">Derivative liabilities</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">1,016,865</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"> </p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">1,016,865</p></td><td valign="bottom" width="1%"></td></tr></table><p style="margin:0px;Font:10pt Times New Roman;padding:0px"> </p></div></div>
CY2019	apyp	Warrants Outstanding Weighted Average Remaining Contractual Life WarrantsOutstandingWeightedAverageRemainingContractualLife	P0Y4M17D
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03
CY2019	apyp	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	5000000	shares
CY2019Q2	apyp	Class Of Warrant Or Right Weighted Average Exercise Price ClassOfWarrantOrRightWeightedAverageExercisePrice	0.03
CY2019	apyp	State Of Incorporation StateOfIncorporation	Dakota
CY2019	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2012-11-26
CY2019Q2	apyp	Working Capital Surplus Deficit WorkingCapitalSurplusDeficit	975611	usd
CY2019Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet		usd
CY2018Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	7300	usd
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	257870	usd
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	257870	usd
CY2018Q2	us-gaap	Interest Payable Current InterestPayableCurrent	27177	usd
CY2019Q2	us-gaap	Interest Payable Current InterestPayableCurrent	28794	usd
CY2018Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	290823	usd
CY2019Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	315232	usd
CY2018Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	290823	usd
CY2019Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	315232	usd
CY2018Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2019Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2018Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	345614	usd
CY2019Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	301438	usd
CY2019	apyp	Warrants Outstanding Weighted Average Exercise Price Reset Feature WarrantsOutstandingWeightedAverageExercisePriceResetFeature	0.0000
CY2018	apyp	Warrants Outstanding Weighted Average Exercise Price Reset Feature WarrantsOutstandingWeightedAverageExercisePriceResetFeature	0.0001
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0002
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0004
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	592916818	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5000000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	800000000	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	437235000	shares
CY2019	apyp	Reset Feature ResetFeature	193181818	shares
CY2018	apyp	Reset Feature ResetFeature	150681818	shares
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1586098636	shares
CY2019	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
CY2018	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.0002
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2019Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5000000	shares
CY2018Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	19000	usd
CY2018Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	78947	usd
CY2018Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	78947	usd
CY2019Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount		usd
CY2018Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05	pure
CY2018Q2	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	integer
CY2019Q1	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	integer
CY2018Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0002
CY2019Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0002
CY2018	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	164657	usd
CY2019	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	213365	usd
CY2018	apyp	Derivative Liability Recognized As Debt Discount DerivativeLiabilityRecognizedAsDebtDiscount	277167	usd
CY2019	apyp	Derivative Liability Recognized As Debt Discount DerivativeLiabilityRecognizedAsDebtDiscount	85000	usd
CY2018	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	688234	usd
CY2019	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	302038	usd
CY2018	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	585503747	shares
CY2019	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	3673860559	shares
CY2018	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-295541	usd
CY2019	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-957265	usd
CY2018	apyp	Number Of Lender NumberOfLender	2	integer
CY2019	apyp	Number Of Lender NumberOfLender	2	integer
CY2019Q2	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	387038	usd
CY2018Q2	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	965401	usd
CY2018	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	38447	usd
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	142167	usd
CY2019Q2	apyp	Class Of Warrant Or Right Exercisable Of Common Stock Shares ClassOfWarrantOrRightExercisableOfCommonStockShares	42500000	shares
CY2019	apyp	Class Of Warrant Or Right Exercisable Price Per Share ClassOfWarrantOrRightExercisablePricePerShare	0.000055
CY2018Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2019Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0001
CY2019	apyp	Class Of Warrant Or Right With Reset Feature ClassOfWarrantOrRightWithResetFeature	193181818	shares
CY2018	apyp	Class Of Warrant Or Right With Reset Feature ClassOfWarrantOrRightWithResetFeature	150681818	shares
CY2019Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	116666	usd
CY2018Q2	apyp	Debt Instrument Interest Rate Default Percentage DebtInstrumentInterestRateDefaultPercentage	24	usd
CY2019Q1	apyp	Debt Instrument Interest Rate Default Percentage DebtInstrumentInterestRateDefaultPercentage	55	usd
CY2018Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.0499	pure
CY2019Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent		usd
CY2018Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	8333	usd
CY2019Q2	us-gaap	Notes Payable NotesPayable		usd
CY2018Q2	us-gaap	Notes Payable NotesPayable	8333	usd
CY2019Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent		usd
CY2018Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	644	usd
CY2019Q2	apyp	Debt Instrument Unamortized Discount Related Party Current DebtInstrumentUnamortizedDiscountRelatedPartyCurrent		usd
CY2018Q2	apyp	Debt Instrument Unamortized Discount Related Party Current DebtInstrumentUnamortizedDiscountRelatedPartyCurrent		usd
CY2019Q2	apyp	Convertible Debt Related Party Current And Noncurrent ConvertibleDebtRelatedPartyCurrentAndNoncurrent		usd
CY2018Q2	apyp	Convertible Debt Related Party Current And Noncurrent ConvertibleDebtRelatedPartyCurrentAndNoncurrent	8977	usd
CY2018Q2	apyp	Convertible Debt Related Party ConvertibleDebtRelatedParty	8977	usd
CY2019Q2	apyp	Convertible Debt Related Party ConvertibleDebtRelatedParty		usd
CY2019Q2	apyp	Convertible Debt Related Party Noncurrent ConvertibleDebtRelatedPartyNoncurrent		usd
CY2018Q2	apyp	Convertible Debt Related Party Noncurrent ConvertibleDebtRelatedPartyNoncurrent		usd
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	10158	usd
CY2019	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	101597905	shares
CY2019	apyp	Derivative Liability Settled Through Additional Paid In Capital DerivativeLiabilitySettledThroughAdditionalPaidInCapital	30479	usd
CY2018	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	8333	usd
CY2018	apyp	Term Of Promissory Notes TermOfPromissoryNotes	P6M
CY2018Q2	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.08	pure
CY2018	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.45	pure
CY2018Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	9371	usd
CY2019Q2	apyp	Value Assigned To Derivative Liability Recognized As Debt Discount ValueAssignedToDerivativeLiabilityRecognizedAsDebtDiscount	8333	usd
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2019Q2	apyp	New Place Holder Element NewPlaceHolderElement	1016865	usd
CY2018Q2	apyp	New Place Holder Element NewPlaceHolderElement	114316	usd
CY2019	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	461198	usd
CY2019	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan		usd
CY2019	apyp	Settled Due To Conversion Of Debt SettledDueToConversionOfDebt	-987744	usd
CY2018	apyp	Settled Due To Conversion Of Debt SettledDueToConversionOfDebt		usd
CY2019	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	3493	usd
CY2018	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	223318	usd
CY2018Q2	apyp	Ending Balances EndingBalances	1016865	usd
CY2019Q2	apyp	Ending Balances EndingBalances	578812	usd
CY2018	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	-295541	usd
CY2018	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	689272	usd
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	85000	usd
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	285500	usd
CY2018	apyp	Common Stock Issued For The Settlement Shares CommonStockIssuedForTheSettlementShares	75000000	shares
CY2018	apyp	Common Stock Issued For The Settlement Amount CommonStockIssuedForTheSettlementAmount	67500	usd
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2496	usd
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2484	usd
CY2013Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200	usd
CY2013Q1	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3M
CY2013Q1	us-gaap	Description Of Lessee Leasing Arrangements Operating Leases DescriptionOfLesseeLeasingArrangementsOperatingLeases	three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days’ notice prior to expiration of an applicable term
CY2017Q3	apyp	Common Stock Issued For The Settlement Shares CommonStockIssuedForTheSettlementShares		shares
CY2018Q1	apyp	Certificate Of Amendment Description CertificateOfAmendmentDescription	The Company filed a Certificate of Amendment with the state of South Dakota, to the Companys Articles of Incorporation, to increase in the number of authorized shares of its common stock from 1,500,000,000 to 6,000,000,000, par value $0.0001 and to increase the number of authorized Series A Preferred Stock from 5,000,000 to 60,000,000, par value $0.0001.
CY2019Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings		shares
CY2019Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	285000	usd
CY2018Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion		shares
CY2019Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1500	shares
CY2019	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	voting rights of 1,000 shares of common stock
CY2019Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	30000000	shares
CY2017Q2	apyp	Stock Payable To Consulting Services Common Shares Value StockPayableToConsultingServicesCommonSharesValue	105000	usd
CY2019Q2	apyp	Stock Payable To Consulting Services Common Shares Value StockPayableToConsultingServicesCommonSharesValue	47727	usd
CY2018Q2	apyp	Stock Payable To Consulting Services Common Shares Value StockPayableToConsultingServicesCommonSharesValue		usd
CY2017Q2	apyp	Stock Issued During Period Shares Issuable For Consulting Services StockIssuedDuringPeriodSharesIssuableForConsultingServices	55000000	shares
CY2019Q2	apyp	Stock Issued During Period Shares Issuable For Consulting Services StockIssuedDuringPeriodSharesIssuableForConsultingServices	25000000	shares
CY2018Q2	apyp	Stock Issued During Period Shares Issuable For Consulting Services StockIssuedDuringPeriodSharesIssuableForConsultingServices		shares
CY2019	apyp	Number Of Common Stock Issued For Services NumberOfCommonStockIssuedForServices		shares
CY2018	apyp	Number Of Common Stock Issued For Services NumberOfCommonStockIssuedForServices	30000000	shares
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200	usd
CY2019	apyp	Stock Issued Period For Common Stock Payable StockIssuedPeriodForCommonStockPayable		usd
CY2018	apyp	Stock Issued Period For Common Stock Payable StockIssuedPeriodForCommonStockPayable	57273	usd
CY2019Q2	apyp	Certificate Of Amendment Description CertificateOfAmendmentDescription
CY2018	apyp	Certificate Of Amendment Description CertificateOfAmendmentDescription
CY2019	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	usd
CY2018	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	2900	usd
CY2019	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	4750000	shares
CY2019	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	285000	usd
CY2019	apyp	Loss On Settlement Of Debt LossOnSettlementOfDebt	427500	usd
CY2019	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	55	usd
CY2018	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	219755	usd
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-55	usd
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-219755	usd
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2019Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	334068	usd
CY2018Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	556689	usd
CY2019Q2	apyp	Income Tax Reconciliation Income Tax Expense Benefit Defferd Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitDefferdStatutoryIncomeTaxRate	0	usd
CY2018Q2	apyp	Income Tax Reconciliation Income Tax Expense Benefit Defferd Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitDefferdStatutoryIncomeTaxRate	-222676	usd
CY2019Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-334068	usd
CY2018Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-334013	usd
CY2019Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2018Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2019Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1590803	usd

Files In Submission

Name	View Source	Status
0001640334-19-002076-index-headers.html	Edgar Link	pending
0001640334-19-002076-index.html	Edgar Link	pending
0001640334-19-002076.txt	Edgar Link	pending
0001640334-19-002076-xbrl.zip	Edgar Link	pending
apyp-20190630.xsd	Edgar Link	pending
apyp_10k.htm	Edgar Link	pending
apyp_ex211.htm	Edgar Link	pending
apyp_ex311.htm	Edgar Link	pending
apyp_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
apyp-20190630_pre.xml	Edgar Link	unprocessable
apyp-20190630_def.xml	Edgar Link	unprocessable
apyp-20190630_lab.xml	Edgar Link	unprocessable
apyp-20190630.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
apyp-20190630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APYP
APPYEA, INC Stock $apyp

2019 Q2 Form 10-K Financial Statement

#000164033419002076 Filed on October 18, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYP APPYEA, INC Stock $apyp

2019 Q2 Form 10-K Financial Statement

#000164033419002076 Filed on October 18, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYP
APPYEA, INC Stock $apyp